Ronald Jeffrey Bloom, MD | |
711 Cottage Grove Rd, Cottage Grove Cardiology, Bloomfield, CT 06002-3060 | |
(860) 242-8756 | |
(860) 242-3052 |
Full Name | Ronald Jeffrey Bloom |
---|---|
Gender | Male |
Speciality | Cardiovascular Disease (cardiology) |
Experience | 46 Years |
Location | 711 Cottage Grove Rd, Bloomfield, Connecticut |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1548238835 | NPI | - | NPPES |
001258276 | Medicaid | CT | |
060005792 | Other | CT | RAILROAD MEDICARE |
060000233 | Other | CT | MEDICARE |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | 025827 (Connecticut) | Primary |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Hartford Healthcare Medical Group Specialists Pllc | 3173866241 | 1138 |
News Archive
Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.
As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.
Continuity of care in doctor's surgery is key to reducing non-emergency hospital admissions says new research - letting patients see their doctor of choice would cut costs for the NHS.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
The latest approach to islet transplantation, in which clusters of insulin-producing cells known as islets are transplanted from a donor pancreas into another person's liver, has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant.
› Verified 5 days ago
Entity Name | Trinity Health Of New England Provider Network Organization Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1003882812 PECOS PAC ID: 0941113567 Enrollment ID: O20031110000651 |
News Archive
Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.
As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.
Continuity of care in doctor's surgery is key to reducing non-emergency hospital admissions says new research - letting patients see their doctor of choice would cut costs for the NHS.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
The latest approach to islet transplantation, in which clusters of insulin-producing cells known as islets are transplanted from a donor pancreas into another person's liver, has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant.
› Verified 5 days ago
Entity Name | Hartford Healthcare Medical Group Specialists Pllc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1023584216 PECOS PAC ID: 3173866241 Enrollment ID: O20190514001441 |
News Archive
Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.
As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.
Continuity of care in doctor's surgery is key to reducing non-emergency hospital admissions says new research - letting patients see their doctor of choice would cut costs for the NHS.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
The latest approach to islet transplantation, in which clusters of insulin-producing cells known as islets are transplanted from a donor pancreas into another person's liver, has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Ronald Jeffrey Bloom, MD 711 Cottage Grove Rd, Cottage Grove Cardiology, Bloomfield, CT 06002-3060 Ph: (860) 242-8756 | Ronald Jeffrey Bloom, MD 711 Cottage Grove Rd, Cottage Grove Cardiology, Bloomfield, CT 06002-3060 Ph: (860) 242-8756 |
News Archive
Pharmacopeia ( NASDAQ:PCOP ) , an innovator in the discovery and development of novel small molecule therapeutics, today announced positive results from the initial Phase 1 clinical trial of PS433540, the company's lead internal product candidate for the treatment of hypertension and diabetic nephropathy.
As part of the National Blueprint for Injury Prevention in Older Drivers, the Canadian Association of Occupational Therapists (CAOT) has released some important new resources for drivers, their families and health care professionals. A series of information brochures and website (www.olderdriversafety.ca) promoting older driver safety were unveiled today at a public forum held at Ottawa's Good Companions Senior Centre.
Continuity of care in doctor's surgery is key to reducing non-emergency hospital admissions says new research - letting patients see their doctor of choice would cut costs for the NHS.
Neuren Pharmaceuticals Ltd has successfully completed a Phase 1 safety and tolerability trial of its second lead candidate, NNZ-2566, which is being developed to treat traumatic brain injury (TBI).
The latest approach to islet transplantation, in which clusters of insulin-producing cells known as islets are transplanted from a donor pancreas into another person's liver, has produced substantially improved results for patients with type 1 diabetes, and may offer a more durable alternative to a whole pancreas transplant.
› Verified 5 days ago
Richard Siahaan, M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 421 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-0034 Fax: 860-242-3301 | |
Tracy E Patel, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-8756 Fax: 860-242-3052 | |
Dr. Roy A Kellerman, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 35 Jolley Dr Ste 201, Bloomfield, CT 06002 Phone: 860-243-5569 Fax: 860-243-2622 | |
Arthur Bernard Landry Jr., M.D. Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 711 Cottage Grove Rd, Cottage Grove Cardiology, Bloomfield, CT 06002 Phone: 860-242-8756 Fax: 860-769-5009 | |
Dr. Linda Rickman, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 852 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-714-5895 Fax: 860-714-5417 | |
Oksana Kloyzner, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 701 Cottage Grove Rd, Suite F, Bloomfield, CT 06002 Phone: 860-242-4000 Fax: 860-243-8286 | |
Usama Bin Nasir, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 711 Cottage Grove Rd, Bloomfield, CT 06002 Phone: 860-242-8756 |